First published online 5 January 2005
doi: 10.1242/dev.01593
Development 132, 503-513 (2005)
Published by The Company of Biologists 2005
Direct crossregulation between retinoic acid receptor ß and Hox genes during hindbrain segmentation
Patricia Serpente1,
Stefan Tümpel2,
Norbert B. Ghyselinck3,
Karen Niederreither3,*,
Leanne M. Wiedemann2,4,
Pascal Dollé3,
Pierre Chambon3,
Robb Krumlauf2,5 and
Alex P. Gould1,
1 Medical Research Council, National Institute for Medical Research, The
Ridgeway, Mill Hill, London, NW7 1AA, UK
2 Stowers Institute for Medical Research, 1000 East 50th Street, Kansas City, MI
64110, USA
3 Institut de Génétique et de Biologie Moléculaire et
Cellulaire (IGBMC), CNRS/INSERM/ULP/Collège de France, BP10142, 67404
ILLKIRCH Cedex, France
4 Department of Pathology and Laboratory Medicine, Kansas University Medical
Center, Kansas City, KS 66160, USA
5 Department of Anatomy and Cell Biology, Kansas University Medical Center,
Kansas City, KS 66160, USA

View larger version (56K):
[in a new window]
|
Fig. 1. Rarb is expressed more anteriorly than Hoxb4 in the
presegmented hindbrain. The anterior neural expression borders of Hoxb4
protein (A,C,E) and Rarb mRNA (B,D,F) are compared at E8.5 and E9.5.
(A,B) At E9.5, neural expression of both genes extends up to a straight border
at the r6/r7 boundary (arrowhead), lying just caudal to the otic vesicle.
(C,D) At E8.5, using the otic sulcus (Os) as a landmark for presumptive r5/r6,
it can be seen that neural Rarb expression extends more anteriorly
than that of Hoxb4. (E,F) At E8.5, with Krox20 expression marking
presumptive r5, it can be observed that Rarb is expressed in all of
presumptive r6 but Hoxb4 is not. At this stage, the anterior expression border
of both genes is diffuse and, for Rarb, weak expression may also
extend into the posterior part of presumptive r5. Anterior is towards the top
in this and all subsequent figures.
|
|

View larger version (52K):
[in a new window]
|
Fig. 2. Early hindbrain expression of Hoxb4 and Rarb requires
Raldh2 activity. The effects of loss of Raldh2 activity on
the early neural expression of Hoxb4 mRNA (A,B), Hoxb4 protein (C,D)
and Rarb gene (E,F) are shown. (A,B) Dorsal views of E8.5 embryos
showing the Hoxb4 mRNA distribution in Raldh2+/+
(A) and Raldh2-/- (B) genetic backgrounds. Loss of
Raldh2 function is associated with absence of Hoxb4 mRNA
within the hindbrain but expression within the developing spinal cord (sc)
remains unaffected. (C,D) Dorsal views of E8.5 embryos showing Hoxb4 protein
expression in Raldh2+/- (C) and
Raldh2-/- (D) embryos. Removal of Raldh2 activity
leads to loss of most Hoxb4 protein within both the developing hindbrain (hb)
and spinal cord (sc). However, weak expression is still observed within a few
cells at caudal hindbrain and anterior spinal levels. (E,F) Rarb mRNA
induction within the hindbrain requires Raldh2 activity. Lateral
views of E8.5 embryos of the genotypes Raldh2+/- (E) or
Raldh2-/- (F). Loss of Raldh2 activity is
associated with the absence of all detectable Rarb expression within
the developing hindbrain and spinal cord. Os and Ov indicate the otic sulcus
and otic vesicle, lying adjacent to r5 and r6 in this and subsequent figures,
and the approximate position of the paraxial mesodermal limit of
Hoxb4 expression at the somite 6/7 border is also shown (horizontal
line in A-D).
|
|

View larger version (54K):
[in a new window]
|
Fig. 3. Hoxb4 and Hoxd4 regulate the hindbrain expression of
Rarb at late but not at early stages. All panels show the expression
of Rarb mRNA in dorsal views of E9.0-E10.5 embryos lacking from 0 to
4 wild-type alleles of Hoxb4 and Hoxd4. The wild-type
position of the neural Rarb expression border at r6/r7 (arrowhead) is
indicated. (A) E9.0 embryos with Hoxb4+/-;
Hoxd4-/- (left) and Hoxb4-/-;
Hoxd4-/- (right) genotypes showing wild-type patterns of
Rarb expression. At this intermediate stage, although the
Rarb neural border lies in the vicinity of the forming r6/r7
junction, it is not as sharp as at E9.5. (B) E10.5
Hoxb4+/+; Hoxd4-/- embryo with a
normal neural border of Rarb expression at r6/r7. (C,D) E9.5 embryos
that are wild type (C) or Hoxb4-/-;
Hoxd4-/- (D) showing abnormal regression of the Rarb
border associated with loss of function of both Hox paralogues. (E,F)
E10.5 embryos that are wild type (E) or Hoxb4-/-;
Hoxd4-/- (F), showing that, by this late stage, removing the
activity of both Hox paralogues leads to loss of most Rarb
expression from the hindbrain.
|
|

View larger version (43K):
[in a new window]
|
Fig. 4. The Rarb Proximal enhancer recapitulates early neural expression
and responds transiently to RA. All panels show dorsal views of
Rarb2lacZ transgenic embryos at E8-E10.25, histochemically stained
for ß-galactosidase activity. (A,B) E8-E8.5 transgenic embryos at the
two-somite (A) and seven-somite (B) stages. At both time points, strong
reporter expression is present within the neural plate with weaker staining
also visible in paraxial and lateral mesoderm. By the seven-somite stage, a
diffuse anterior border maps to the vicinity of the Os. (C,D) E9.5 embryos of
the genotype Rarb2lacZ/+; Hoxb4+/+;
Hoxd4+/- (C) and Rarb2lacZ/+;
Hoxb4-/-; Hoxd4-/- (D) showing that, at
this late stage, the neural activity of the proximal enhancer is largely
confined to the developing spinal cord with only residual low levels remaining
within the caudal hindbrain. This late pattern is unaffected when the
functions of both Hoxb4 and Hoxd4 are removed. (E,F) E9.25
transgenic embryos treated with an exogenous pulse of RA, showing a clear
ectopic response within r4-r6 at 4 hours (E), but not 24 hours (F), after
treatment. The expression pattern in F is similar to that seen in C.
|
|

View larger version (36K):
[in a new window]
|
Fig. 5. The Rarb Distal enhancer specifies the late r6/r7 border and
requires inputs from Hoxb4 and Hoxd4. Panels show dorsal
views (A) or lateral views (B-H) of Rarb1lacZ transgenic embryos at
E8.5-E10.5, histochemically stained for ß-galactosidase activity. (A,B)
An E8.5 transgenic embryo (A) and a E9.5 transgenic embryo (B), indicating
that distal enhancer activity is initiated after E8.5 and by E9.5 is
restricted to the dorsal neural tube with a sharp border at r6/r7. (C,D)
Transgenic embryos treated with a single dose of RA at E9.25 and allowed to
develop in utero for either 4 hours (C) or 24 hours (D). No ectopic response
to RA is detected in either case. (E-H) E10.5 transgenic embryos carrying
various combinations of Hoxb4 and Hoxd4 loss-of-function
alleles. Strong distal enhancer activity is seen in Rarb1lacZ/+;
Hoxb4+/+; Hoxd4+/- (E), weak distal
enhancer activity in Rarb1lacZ/+; Hoxb4+/-;
Hoxd4+/- (F) and Rarb1lacZ/+;
Hoxb4+/-; Hoxd4-/- (G) and no detectable
distal enhancer activity in Rarb1lacZ/+;
Hoxb4-/-; Hoxd4-/- embryos (H).
|
|
© The Company of Biologists Ltd 2005